 | • レポートコード：D005-06017 • 出版社/出版日：GlobalInfoResearch / 2020年5月22日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、脳炎ワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。脳炎ワクチンの種類別市場規模（中山、北京、P-3、SA14-14-2）、用途別市場規模（子供、成人）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Liaoning Chengda、Lanzhou Institute of Biological Products、Tiantan Biological Products、Wuhan Institute of Biological、GlaxoSmithKline、Valneva、Biken、Chengdu Institute of Biological Products、Sanofi Pasteur、Zhejiang Tianyuan Bio-Pharmaceutical ・地域別グローバル市場分析 2015年-2020年 ・脳炎ワクチンの北米市場（アメリカ、カナダ、メキシコ） ・脳炎ワクチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・脳炎ワクチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・脳炎ワクチンの南米市場（ブラジル、アルゼンチン） ・脳炎ワクチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：中山、北京、P-3、SA14-14-2 ・用途別分析：子供、成人 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Encephalitis Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.4% in the forecast period of 2020 to 2025 and will expected to reach USD 1461.8 million by 2025, from USD 1186.3 million in 2019.
The Encephalitis Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Encephalitis Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Encephalitis Vaccine market has been segmented into
Nakayama
Beijing
P-3
SA 14-14-2
By Application, Encephalitis Vaccine has been segmented into:
Child
Adult
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Encephalitis Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Encephalitis Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Encephalitis Vaccine market.
The report offers in-depth assessment of the growth and other aspects of the Encephalitis Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Encephalitis Vaccine Market Share Analysis
Encephalitis Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Encephalitis Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Encephalitis Vaccine sales, revenue and market share for each player covered in this report.
The major players covered in Encephalitis Vaccine are:
Liaoning Chengda
Lanzhou Institute of Biological Products
Tiantan Biological Products
Wuhan Institute of Biological
GlaxoSmithKline
Valneva
Biken
Chengdu Institute of Biological Products
Sanofi Pasteur
Zhejiang Tianyuan Bio-Pharmaceutical
Among other players domestic and global, Encephalitis Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Encephalitis Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Encephalitis Vaccine, with price, sales, revenue and global market share of Encephalitis Vaccine in 2018 and 2019.
Chapter 3, the Encephalitis Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Encephalitis Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Encephalitis Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Encephalitis Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Encephalitis Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Encephalitis Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Nakayama
1.2.3 Beijing
1.2.4 P-3
1.2.5 SA 14-14-2
1.3 Market Analysis by Application
1.3.1 Overview: Global Encephalitis Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Child
1.3.3 Adult
1.4 Overview of Global Encephalitis Vaccine Market
1.4.1 Global Encephalitis Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Liaoning Chengda
2.1.1 Liaoning Chengda Details
2.1.2 Liaoning Chengda Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Liaoning Chengda SWOT Analysis
2.1.4 Liaoning Chengda Product and Services
2.1.5 Liaoning Chengda Encephalitis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Lanzhou Institute of Biological Products
2.2.1 Lanzhou Institute of Biological Products Details
2.2.2 Lanzhou Institute of Biological Products Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Lanzhou Institute of Biological Products SWOT Analysis
2.2.4 Lanzhou Institute of Biological Products Product and Services
2.2.5 Lanzhou Institute of Biological Products Encephalitis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Tiantan Biological Products
2.3.1 Tiantan Biological Products Details
2.3.2 Tiantan Biological Products Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Tiantan Biological Products SWOT Analysis
2.3.4 Tiantan Biological Products Product and Services
2.3.5 Tiantan Biological Products Encephalitis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Wuhan Institute of Biological
2.4.1 Wuhan Institute of Biological Details
2.4.2 Wuhan Institute of Biological Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Wuhan Institute of Biological SWOT Analysis
2.4.4 Wuhan Institute of Biological Product and Services
2.4.5 Wuhan Institute of Biological Encephalitis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 GlaxoSmithKline SWOT Analysis
2.5.4 GlaxoSmithKline Product and Services
2.5.5 GlaxoSmithKline Encephalitis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Valneva
2.6.1 Valneva Details
2.6.2 Valneva Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Valneva SWOT Analysis
2.6.4 Valneva Product and Services
2.6.5 Valneva Encephalitis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Biken
2.7.1 Biken Details
2.7.2 Biken Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Biken SWOT Analysis
2.7.4 Biken Product and Services
2.7.5 Biken Encephalitis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Chengdu Institute of Biological Products
2.8.1 Chengdu Institute of Biological Products Details
2.8.2 Chengdu Institute of Biological Products Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Chengdu Institute of Biological Products SWOT Analysis
2.8.4 Chengdu Institute of Biological Products Product and Services
2.8.5 Chengdu Institute of Biological Products Encephalitis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Sanofi Pasteur
2.9.1 Sanofi Pasteur Details
2.9.2 Sanofi Pasteur Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Sanofi Pasteur SWOT Analysis
2.9.4 Sanofi Pasteur Product and Services
2.9.5 Sanofi Pasteur Encephalitis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Zhejiang Tianyuan Bio-Pharmaceutical
2.10.1 Zhejiang Tianyuan Bio-Pharmaceutical Details
2.10.2 Zhejiang Tianyuan Bio-Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Zhejiang Tianyuan Bio-Pharmaceutical SWOT Analysis
2.10.4 Zhejiang Tianyuan Bio-Pharmaceutical Product and Services
2.10.5 Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Encephalitis Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Encephalitis Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Encephalitis Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 Encephalitis Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Encephalitis Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Encephalitis Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Encephalitis Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America Encephalitis Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe Encephalitis Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Encephalitis Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Encephalitis Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Encephalitis Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Encephalitis Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Encephalitis Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America Encephalitis Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States Encephalitis Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada Encephalitis Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico Encephalitis Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Encephalitis Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Encephalitis Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Encephalitis Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany Encephalitis Vaccine Sales and Growth Rate (2015-2020)
6.3 UK Encephalitis Vaccine Sales and Growth Rate (2015-2020)
6.4 France Encephalitis Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia Encephalitis Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy Encephalitis Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Encephalitis Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Encephalitis Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Encephalitis Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China Encephalitis Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan Encephalitis Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea Encephalitis Vaccine Sales and Growth Rate (2015-2020)
7.5 India Encephalitis Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Encephalitis Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia Encephalitis Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Encephalitis Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Encephalitis Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America Encephalitis Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Encephalitis Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina Encephalitis Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Encephalitis Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Encephalitis Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Encephalitis Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Encephalitis Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey Encephalitis Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Encephalitis Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa Encephalitis Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Encephalitis Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global Encephalitis Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global Encephalitis Vaccine Price by Type (2015-2020)
11 Global Encephalitis Vaccine Market Segment by Application
11.1 Global Encephalitis Vaccine Sales Market Share by Application (2015-2020)
11.2 Global Encephalitis Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global Encephalitis Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Encephalitis Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 Encephalitis Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America Encephalitis Vaccine Market Forecast (2021-2025)
12.2.2 Europe Encephalitis Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Encephalitis Vaccine Market Forecast (2021-2025)
12.2.4 South America Encephalitis Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Encephalitis Vaccine Market Forecast (2021-2025)
12.3 Encephalitis Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global Encephalitis Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global Encephalitis Vaccine Market Share Forecast by Type (2021-2025)
12.4 Encephalitis Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global Encephalitis Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global Encephalitis Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Encephalitis Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Encephalitis Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Encephalitis Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Liaoning Chengda Basic Information, Manufacturing Base and Competitors
Table 8. Liaoning Chengda Encephalitis Vaccine Major Business
Table 9. Liaoning Chengda Encephalitis Vaccine Total Revenue (USD Million) (2017-2018)
Table 10. Liaoning Chengda SWOT Analysis
Table 11. Liaoning Chengda Encephalitis Vaccine Product and Services
Table 12. Liaoning Chengda Encephalitis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Lanzhou Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 14. Lanzhou Institute of Biological Products Encephalitis Vaccine Major Business
Table 15. Lanzhou Institute of Biological Products Encephalitis Vaccine Total Revenue (USD Million) (2017-2018)
Table 16. Lanzhou Institute of Biological Products SWOT Analysis
Table 17. Lanzhou Institute of Biological Products Encephalitis Vaccine Product and Services
Table 18. Lanzhou Institute of Biological Products Encephalitis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Tiantan Biological Products Basic Information, Manufacturing Base and Competitors
Table 20. Tiantan Biological Products Encephalitis Vaccine Major Business
Table 21. Tiantan Biological Products Encephalitis Vaccine Total Revenue (USD Million) (2017-2018)
Table 22. Tiantan Biological Products SWOT Analysis
Table 23. Tiantan Biological Products Encephalitis Vaccine Product and Services
Table 24. Tiantan Biological Products Encephalitis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Wuhan Institute of Biological Basic Information, Manufacturing Base and Competitors
Table 26. Wuhan Institute of Biological Encephalitis Vaccine Major Business
Table 27. Wuhan Institute of Biological Encephalitis Vaccine Total Revenue (USD Million) (2017-2018)
Table 28. Wuhan Institute of Biological SWOT Analysis
Table 29. Wuhan Institute of Biological Encephalitis Vaccine Product and Services
Table 30. Wuhan Institute of Biological Encephalitis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 32. GlaxoSmithKline Encephalitis Vaccine Major Business
Table 33. GlaxoSmithKline Encephalitis Vaccine Total Revenue (USD Million) (2017-2018)
Table 34. GlaxoSmithKline SWOT Analysis
Table 35. GlaxoSmithKline Encephalitis Vaccine Product and Services
Table 36. GlaxoSmithKline Encephalitis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Valneva Basic Information, Manufacturing Base and Competitors
Table 38. Valneva Encephalitis Vaccine Major Business
Table 39. Valneva Encephalitis Vaccine Total Revenue (USD Million) (2017-2018)
Table 40. Valneva SWOT Analysis
Table 41. Valneva Encephalitis Vaccine Product and Services
Table 42. Valneva Encephalitis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Biken Basic Information, Manufacturing Base and Competitors
Table 44. Biken Encephalitis Vaccine Major Business
Table 45. Biken Encephalitis Vaccine Total Revenue (USD Million) (2017-2018)
Table 46. Biken SWOT Analysis
Table 47. Biken Encephalitis Vaccine Product and Services
Table 48. Biken Encephalitis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Chengdu Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 50. Chengdu Institute of Biological Products Encephalitis Vaccine Major Business
Table 51. Chengdu Institute of Biological Products Encephalitis Vaccine Total Revenue (USD Million) (2017-2018)
Table 52. Chengdu Institute of Biological Products SWOT Analysis
Table 53. Chengdu Institute of Biological Products Encephalitis Vaccine Product and Services
Table 54. Chengdu Institute of Biological Products Encephalitis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 56. Sanofi Pasteur Encephalitis Vaccine Major Business
Table 57. Sanofi Pasteur Encephalitis Vaccine Total Revenue (USD Million) (2017-2018)
Table 58. Sanofi Pasteur SWOT Analysis
Table 59. Sanofi Pasteur Encephalitis Vaccine Product and Services
Table 60. Sanofi Pasteur Encephalitis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Zhejiang Tianyuan Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 62. Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Major Business
Table 63. Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Total Revenue (USD Million) (2017-2018)
Table 64. Zhejiang Tianyuan Bio-Pharmaceutical SWOT Analysis
Table 65. Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Product and Services
Table 66. Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Encephalitis Vaccine Sales by Manufacturer (2018-2019) (M Doses)
Table 68. Global Encephalitis Vaccine Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Encephalitis Vaccine Sales by Regions (2015-2020) (M Doses)
Table 70. Global Encephalitis Vaccine Sales Market Share by Regions (2015-2020)
Table 71. Global Encephalitis Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Encephalitis Vaccine Sales by Countries (2015-2020) (M Doses)
Table 73. North America Encephalitis Vaccine Sales Market Share by Countries (2015-2020)
Table 74. North America Encephalitis Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Encephalitis Vaccine Revenue Market Share by Countries (2015-2020)
Table 76. Europe Encephalitis Vaccine Sales by Countries (2015-2020) (M Doses)
Table 77. Europe Encephalitis Vaccine Sales Market Share by Countries (2015-2020)
Table 78. Europe Encephalitis Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Encephalitis Vaccine Sales by Regions (2015-2020) (M Doses)
Table 80. Asia-Pacific Encephalitis Vaccine Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Encephalitis Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Encephalitis Vaccine Sales by Countries (2015-2020) (M Doses)
Table 83. South America Encephalitis Vaccine Sales Market Share by Countries (2015-2020)
Table 84. South America Encephalitis Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Encephalitis Vaccine Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Encephalitis Vaccine Sales by Countries (2015-2020) (M Doses)
Table 87. Middle East & Africa Encephalitis Vaccine Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Encephalitis Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Encephalitis Vaccine Revenue Market Share by Countries (2015-2020)
Table 90. Global Encephalitis Vaccine Sales by Type (2015-2020) (M Doses)
Table 91. Global Encephalitis Vaccine Sales Share by Type (2015-2020)
Table 92. Global Encephalitis Vaccine Revenue by Type (2015-2020) (USD Million)
Table 93. Global Encephalitis Vaccine Revenue Share by Type (2015-2020)
Table 94. Global Encephalitis Vaccine Sales by Application (2015-2020) (M Doses)
Table 95. Global Encephalitis Vaccine Sales Share by Application (2015-2020)
Table 96. Global Encephalitis Vaccine Sales Forecast by Regions (2021-2025) (M Doses)
Table 97. Global Encephalitis Vaccine Market Share Forecast by Regions (2021-2025)
Table 98. Global Encephalitis Vaccine Sales Forecast by Type (2021-2025) (M Doses)
Table 99. Global Encephalitis Vaccine Market Share Forecast by Type (2021-2025)
Table 100. Global Encephalitis Vaccine Sales Forecast by Application (2021-2025)
Table 101. Global Encephalitis Vaccine Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Encephalitis Vaccine Picture
Figure 2. Global Sales Market Share of Encephalitis Vaccine by Type in 2019
Figure 3. Nakayama Picture
Figure 4. Beijing Picture
Figure 5. P-3 Picture
Figure 6. SA 14-14-2 Picture
Figure 7. Encephalitis Vaccine Sales Market Share by Application in 2018
Figure 8. Child Picture
Figure 9. Adult Picture
Figure 10. Global Encephalitis Vaccine Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Encephalitis Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Encephalitis Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Encephalitis Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Encephalitis Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Encephalitis Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Encephalitis Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Encephalitis Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Encephalitis Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Encephalitis Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Encephalitis Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Encephalitis Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Encephalitis Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Encephalitis Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Encephalitis Vaccine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Encephalitis Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Encephalitis Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Encephalitis Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Encephalitis Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Encephalitis Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Encephalitis Vaccine Sales Market Share by Manufacturer in 2019
Figure 31. Global Encephalitis Vaccine Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Encephalitis Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Encephalitis Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Encephalitis Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 36. Global Encephalitis Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Encephalitis Vaccine Revenue Market Share by Regions (2015-2020)
Figure 38. Global Encephalitis Vaccine Revenue Market Share by Regions in 2018
Figure 39. North America Encephalitis Vaccine Sales and Growth Rate (2015-2020)
Figure 40. Europe Encephalitis Vaccine Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Encephalitis Vaccine Sales and Growth Rate (2015-2020)
Figure 42. South America Encephalitis Vaccine Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Encephalitis Vaccine Sales and Growth Rate (2015-2020)
Figure 44. North America Encephalitis Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Encephalitis Vaccine Sales Market Share by Countries (2015-2020)
Figure 46. North America Encephalitis Vaccine Sales Market Share by Countries in 2018
Figure 47. North America Encephalitis Vaccine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Encephalitis Vaccine Revenue Market Share by Countries in 2018
Figure 49. United States Encephalitis Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 50. Canada Encephalitis Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 51. Mexico Encephalitis Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 52. Europe Encephalitis Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Encephalitis Vaccine Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Encephalitis Vaccine Revenue Market Share by Countries in 2019
Figure 55. Germany Encephalitis Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 56. UK Encephalitis Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 57. France Encephalitis Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 58. Russia Encephalitis Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 59. Italy Encephalitis Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 60. Asia-Pacific Encephalitis Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Encephalitis Vaccine Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Encephalitis Vaccine Revenue Market Share by Regions 2019
Figure 63. China Encephalitis Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 64. Japan Encephalitis Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 65. Korea Encephalitis Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 66. India Encephalitis Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 67. Southeast Asia Encephalitis Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 68. South America Encephalitis Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Encephalitis Vaccine Sales Market Share by Countries in 2019
Figure 70. South America Encephalitis Vaccine Revenue Market Share by Countries in 2019
Figure 71. Brazil Encephalitis Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 72. Argentina Encephalitis Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 73. Middle East and Africa Encephalitis Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Encephalitis Vaccine Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Encephalitis Vaccine Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Encephalitis Vaccine Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Encephalitis Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 78. Egypt Encephalitis Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 79. Turkey Encephalitis Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 80. South Africa Encephalitis Vaccine Sales and Growth Rate (2015-2020) (M Doses)
Figure 81. Global Encephalitis Vaccine Sales and Growth Rate (2021-2025) (M Doses)
Figure 82. Global Encephalitis Vaccine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Encephalitis Vaccine Market Forecast (2021-2025) (M Doses)
Figure 84. Europe Sales Encephalitis Vaccine Market Forecast (2021-2025) (M Doses)
Figure 85. Asia-Pacific Sales Encephalitis Vaccine Market Forecast (2021-2025) (M Doses)
Figure 86. South America Sales Encephalitis Vaccine Market Forecast (2021-2025) (M Doses)
Figure 87. Middle East & Africa Sales Encephalitis Vaccine Market Forecast (2021-2025) (M Doses)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
日本脳炎ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Japanese Encephalitis (JE) Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Japanese E…- 肺炎球菌ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Summary Market Overview The global Pneumococcal Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 1.1% in the forecast period of 2020 to 2025 and will expected to reach USD 7551.8 million by 2025, from USD 7242 million in 2019. The Pneumococ…
- 麻疹ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Measle Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Measle Vaccine market report p…
- ライム病ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Lyme Disease Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Lyme Disease Vaccine mar…
- イヌインフルエンザワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Canine Influenza Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Canine Influenza Vac…